Davis's Drug Guide
Beyaz
Phase I
drospirenone 3 mg + ethinyl estradiol 20 mcg + levomefolate 0.451 mg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Beyaz." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109775/all/Beyaz.
Vallerand AHA, Sanoski CAC. Beyaz. Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109775/all/Beyaz. Accessed July 1, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Beyaz. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109775/all/Beyaz
Vallerand AHA, Sanoski CAC. Beyaz [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109775/all/Beyaz.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beyaz
ID - 109775
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109775/all/Beyaz
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
